NYSE · CIK 0000785161
EHC Encompass Health Corp
Insider trading from SEC Form 4. Last filing 41 d ago. Close $123.33 on Oct 9, 2026, +32% from the 52-week low and -2% from the high.
Last 90 days
Net insider value
-$1.2M
more sold than bought
Buys
0
$0 by 0 insiders
Sells
2
$1.2M by 2 insiders
Insiders on file
16
with a Form 4 at this company
Price and insider trades, last year
EHCOct 9, 2026 · close 123.33
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Encompass Health Corp, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 27Weak | John Patrick Darby EVP, Gen Counsel & Secretary sell | $588k 4,858 shares | -6% | - | |
| 43Moderate | Andrew L Price Chief Accounting Officer sell | $630k 5,211 shares | -7% | - | |
| 48Moderate | Mark J Tarr President & CEO sell | $14M 118,384 shares | -18% | +34% from low0% from high | |
| 58Moderate | Elissa Joy Charbonneau Chief Medical Officer sell | $499k 4,279 shares | -26% | +29% from low0% from high | |
| 57Moderate | Douglas E Coltharp EVP & Chief Financial Officer sell | $5.0M 43,575 shares | -42% | +28% from low0% from high | |
| 45Moderate | John Patrick Darby EVP, Gen Counsel & Secretary sell | $1.1M 10,000 shares | -11% | +28% from low0% from high | |
| 33Weak | Andrew L Price Chief Accounting Officer sell | $496k 5,042 shares | -7% | - |
Congressional trades
4 trades in EHC disclosed by members of Congress under the STOCK Act. All congressional trades.
- Lisa C. McClainHouse · R-MI · last Nov 21, 20252 bought
2 sold
| Member | Trade | Asset | Reported range | Trade / filing date | Source |
|---|---|---|---|---|---|
Lisa C. McClain House · R-MI | Purchase | EHC Encompass Health Corporation Common Stock | $1,001 to $15k | Oct 30, 2025 / Nov 21, 2025 22 days after the trade | Clerk |
Lisa C. McClain House · R-MI | Sale | EHC Encompass Health Corporation Common Stock | $1,001 to $15k | Oct 30, 2025 / Nov 21, 2025 22 days after the trade | Clerk |
Lisa C. McClain House · R-MI | Sale | EHC Encompass Health Corporation Common Stock | $1,001 to $15k | Oct 31, 2025 / Nov 21, 2025 21 days after the trade | Clerk |
Lisa C. McClain House · R-MI | Purchase | EHC Encompass Health Corporation Common Stock | $1,001 to $15k | Jul 22, 2025 / Aug 13, 2025 22 days after the trade | Clerk |
Transactions
The last 100 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | Andrew L Price Chief Accounting Officer | SOpen-market sale Encompass Health Common Stock | -5,211 | $120.93 | $630k | 69,483 | 41 d ago |
| Aug 31, 2026 | John Patrick Darby EVP, Gen Counsel & Secretary | MOption exercise Encompass Health Common Stock | +4,858 | $35.06 | $170k | 79,899 | 41 d ago |
| Aug 31, 2026 | John Patrick Darby EVP, Gen Counsel & Secretary | SOpen-market sale Encompass Health Common Stock | -4,858 | $121.09 | $588k | 75,041 | 41 d ago |
| Aug 31, 2026 | John Patrick Darby EVP, Gen Counsel & Secretary | MOption exercise Non-qualified Stock Option (Right to Buy)derivative | -4,858 | $0.00 | $0 | 0 | 41 d ago |
| Aug 21, 2025 | Douglas E Coltharp EVP & Chief Financial Officer | GGift Encompass Health Common Stockindirect: By spouse | -27,480 | $0.00 | $0 | 37,749 | Aug 21, 2025 |
| Aug 21, 2025 | Douglas E Coltharp EVP & Chief Financial Officer | GGift Encompass Health Common Stockindirect: By irrevocable trust | +27,480 | $0.00 | $0 | 27,480 | Aug 21, 2025 |
| Jul 15, 2025 | Edward M Christie III director | AGrant or award Encompass Health Common Stock | +8 | $0.00 | $0 | 6,414 | Jul 16, 2025 |
| Jul 15, 2025 | Greg D Carmichael director | AGrant or award Encompass Health Common Stock | +24 | $0.00 | $0 | 18,608 | Jul 16, 2025 |
| Jul 16, 2025 | Edward M Christie III director | AGrant or award Encompass Health Common Stock | +260 | $106.48 | $28k | 6,674 | Jul 16, 2025 |
| May 20, 2025 | Mark J Tarr President & CEO | MOption exercise Encompass Health Common Stock | +56,306 | $35.06 | $2.0M | 583,376 | May 20, 2025 |
| May 20, 2025 | Mark J Tarr President & CEO | MOption exercise Encompass Health Common Stock | +62,078 | $44.67 | $2.8M | 645,454 | May 20, 2025 |
| May 20, 2025 | Mark J Tarr President & CEO | SOpen-market sale Encompass Health Common Stock | -94 | $120.94 | $11k | 645,360 | May 20, 2025 |
| May 20, 2025 | Mark J Tarr President & CEO | SOpen-market sale Encompass Health Common Stock | -118,290 | $121.53 | $14M | 527,070 | May 20, 2025 |
| May 20, 2025 | Mark J Tarr President & CEO | MOption exercise Non-qualified Stock Option (Right to Buy)derivative | -56,306 | $0.00 | $0 | 0 | May 20, 2025 |
| May 20, 2025 | Mark J Tarr President & CEO | MOption exercise Non-qualified Stock Option (Right to Buy)derivative | -62,078 | $0.00 | $0 | 0 | May 20, 2025 |
| May 14, 2025 | Edmund Fay Sr. Vice Pres. and Treasurer | GGift Encompass Health Common Stock | -3,667 | $0.00 | $0 | 96,489 | May 15, 2025 |
| May 6, 2025 | Elissa Joy Charbonneau Chief Medical Officer | SOpen-market sale Encompass Health Common Stock | -4,279 | $116.61 | $499k | 11,958 | May 7, 2025 |
| May 1, 2025 | Greg D Carmichael director | AGrant or award Encompass Health Common Stock | +1,424 | $0.00 | $0 | 18,584 | May 2, 2025 |
| May 1, 2025 | Edward M Christie III director | AGrant or award Encompass Health Common Stock | +1,424 | $0.00 | $0 | 6,406 | May 2, 2025 |
| May 1, 2025 | Terrance Williams director | AGrant or award Encompass Health Common Stock | +1,424 | $0.00 | $0 | 15,094 | May 2, 2025 |
| May 1, 2025 | Nancy M Schlichting director | AGrant or award Encompass Health Common Stock | +1,424 | $0.00 | $0 | 21,152 | May 2, 2025 |
| May 1, 2025 | Christopher R Reidy director | AGrant or award Encompass Health Common Stock | +1,424 | $0.00 | $0 | 14,431 | May 2, 2025 |
| May 1, 2025 | Kevin J. O'Connor director | AGrant or award Encompass Health Common Stock | +1,424 | $0.00 | $0 | 9,866 | May 2, 2025 |
| May 1, 2025 | Patricia Anne Maryland director | AGrant or award Encompass Health Common Stock | +1,424 | $0.00 | $0 | 14,740 | May 2, 2025 |
| May 1, 2025 | Leslye G Katz director | AGrant or award Encompass Health Common Stock | +1,424 | $0.00 | $0 | 47,605 | May 2, 2025 |
| May 1, 2025 | Joan E Herman director | AGrant or award Encompass Health Common Stock | +1,424 | $0.00 | $0 | 47,605 | May 2, 2025 |
| Apr 30, 2025 | Patrick William Tuer EVP, Chief Operating Officer | AGrant or award Encompass Health Common Stock | +5,984 | $0.00 | $0 | 19,866 | May 1, 2025 |
| Apr 29, 2025 | John Patrick Darby EVP, Gen Counsel & Secretary | MOption exercise Encompass Health Common Stock | +10,000 | $35.06 | $351k | 89,710 | Apr 30, 2025 |
| Apr 29, 2025 | Douglas E Coltharp EVP & Chief Financial Officer | MOption exercise Encompass Health Common Stock | +16,075 | $29.06 | $467k | 76,410 | Apr 30, 2025 |
| Apr 29, 2025 | John Patrick Darby EVP, Gen Counsel & Secretary | SOpen-market sale Encompass Health Common Stock | -10,000 | $114.79 | $1.1M | 79,710 | Apr 30, 2025 |
| Apr 29, 2025 | Douglas E Coltharp EVP & Chief Financial Officer | MOption exercise Encompass Health Common Stock | +27,500 | $32.94 | $906k | 103,910 | Apr 30, 2025 |
| Apr 29, 2025 | John Patrick Darby EVP, Gen Counsel & Secretary | MOption exercise Non-qualified Stock Option (Right to Buy)derivative | -10,000 | $0.00 | $0 | 4,858 | Apr 30, 2025 |
| Apr 29, 2025 | Douglas E Coltharp EVP & Chief Financial Officer | SOpen-market sale Encompass Health Common Stock | -26,239 | $114.78 | $3.0M | 77,671 | Apr 30, 2025 |
| Apr 29, 2025 | Douglas E Coltharp EVP & Chief Financial Officer | SOpen-market sale Encompass Health Common Stock | -13,402 | $115.51 | $1.5M | 64,269 | Apr 30, 2025 |
| Apr 29, 2025 | Douglas E Coltharp EVP & Chief Financial Officer | SOpen-market sale Encompass Health Common Stock | -3,934 | $116.36 | $458k | 60,335 | Apr 30, 2025 |
| Apr 29, 2025 | Douglas E Coltharp EVP & Chief Financial Officer | MOption exercise Non-qualified Stock Option (Right to Buy)derivative | -16,075 | $0.00 | $0 | 0 | Apr 30, 2025 |
| Apr 29, 2025 | Douglas E Coltharp EVP & Chief Financial Officer | MOption exercise Non-qualified Stock Option (Right to Buy)derivative | -27,500 | $0.00 | $0 | 27,694 | Apr 30, 2025 |
| Apr 24, 2025 | Edward M Christie III director | AGrant or award Encompass Health Common Stock | +268 | $102.56 | $27k | 4,982 | Apr 24, 2025 |
| Apr 22, 2025 | Christopher R Reidy director | AGrant or award Encompass Health Common Stock | +360 | $98.23 | $35k | 13,007 | Apr 23, 2025 |
| Apr 15, 2025 | Greg D Carmichael director | AGrant or award Encompass Health Common Stock | +23 | $0.00 | $0 | 17,160 | Apr 16, 2025 |
| Apr 15, 2025 | Edward M Christie III director | AGrant or award Encompass Health Common Stock | +5 | $0.00 | $0 | 4,714 | Apr 16, 2025 |
| Apr 15, 2025 | Terrance Williams director | AGrant or award Encompass Health Common Stock | +23 | $0.00 | $0 | 13,670 | Apr 16, 2025 |
| Apr 15, 2025 | Nancy M Schlichting director | AGrant or award Encompass Health Common Stock | +33 | $0.00 | $0 | 19,728 | Apr 16, 2025 |
| Apr 15, 2025 | Leslye G Katz director | AGrant or award Encompass Health Common Stock | +76 | $0.00 | $0 | 46,181 | Apr 16, 2025 |
| Apr 15, 2025 | Christopher R Reidy director | AGrant or award Encompass Health Common Stock | +15 | $0.00 | $0 | 12,647 | Apr 16, 2025 |
| Apr 15, 2025 | Joan E Herman director | AGrant or award Encompass Health Common Stock | +76 | $0.00 | $0 | 46,181 | Apr 16, 2025 |
| Apr 15, 2025 | Kevin J. O'Connor director | AGrant or award Encompass Health Common Stock | +13 | $0.00 | $0 | 8,442 | Apr 16, 2025 |
| Apr 15, 2025 | Patricia Anne Maryland director | AGrant or award Encompass Health Common Stock | +23 | $0.00 | $0 | 13,316 | Apr 16, 2025 |
| Mar 4, 2025 | Douglas E Coltharp EVP & Chief Financial Officer | AGrant or award Non-qualified Stock Option (Right to Buy)derivative | +12,407 | $98.45 | $1.2M | 12,407 | Mar 5, 2025 |
| Mar 4, 2025 | John Patrick Darby EVP, Gen Counsel & Secretary | AGrant or award Non-qualified Stock Option (Right to Buy)derivative | +6,032 | $98.45 | $594k | 6,032 | Mar 5, 2025 |
| Mar 4, 2025 | Mark J Tarr President & CEO | AGrant or award Non-qualified Stock Option (Right to Buy)derivative | +33,086 | $98.45 | $3.3M | 33,086 | Mar 5, 2025 |
| Feb 28, 2025 | Douglas E Coltharp EVP & Chief Financial Officer | FTax withholding Encompass Health Common Stock | -776 | $100.14 | $78k | 60,335 | Mar 3, 2025 |
| Feb 28, 2025 | Elissa Joy Charbonneau Chief Medical Officer | FTax withholding Encompass Health Common Stock | -364 | $100.14 | $36k | 16,237 | Mar 3, 2025 |
| Feb 28, 2025 | John Patrick Darby EVP, Gen Counsel & Secretary | FTax withholding Encompass Health Common Stock | -416 | $100.14 | $42k | 79,710 | Mar 3, 2025 |
| Feb 28, 2025 | Andrew L Price Chief Accounting Officer | FTax withholding Encompass Health Common Stock | -304 | $100.14 | $30k | 69,587 | Mar 3, 2025 |
| Feb 28, 2025 | Edmund Fay Sr. Vice Pres. and Treasurer | FTax withholding Encompass Health Common Stock | -276 | $100.14 | $28k | 100,156 | Mar 3, 2025 |
| Feb 28, 2025 | Mark J Tarr President & CEO | FTax withholding Encompass Health Common Stock | -2,187 | $100.14 | $219k | 527,070 | Mar 3, 2025 |
| Feb 24, 2025 | Douglas E Coltharp EVP & Chief Financial Officer | FTax withholding Encompass Health Common Stock | -927 | $97.53 | $90k | 62,190 | Feb 26, 2025 |
| Feb 24, 2025 | Elissa Joy Charbonneau Chief Medical Officer | FTax withholding Encompass Health Common Stock | -435 | $97.53 | $42k | 17,107 | Feb 26, 2025 |
| Feb 24, 2025 | John Patrick Darby EVP, Gen Counsel & Secretary | FTax withholding Encompass Health Common Stock | -437 | $97.53 | $43k | 80,635 | Feb 26, 2025 |
| Feb 24, 2025 | Andrew L Price Chief Accounting Officer | FTax withholding Encompass Health Common Stock | -401 | $97.53 | $39k | 70,301 | Feb 26, 2025 |
| Feb 24, 2025 | Mark J Tarr President & CEO | FTax withholding Encompass Health Common Stock | -2,488 | $97.53 | $243k | 532,153 | Feb 26, 2025 |
| Feb 24, 2025 | Edmund Fay Sr. Vice Pres. and Treasurer | FTax withholding Encompass Health Common Stock | -374 | $97.53 | $36k | 100,816 | Feb 26, 2025 |
| Feb 25, 2025 | Douglas E Coltharp EVP & Chief Financial Officer | FTax withholding Encompass Health Common Stock | -1,079 | $100.63 | $109k | 61,111 | Feb 26, 2025 |
| Feb 25, 2025 | Elissa Joy Charbonneau Chief Medical Officer | FTax withholding Encompass Health Common Stock | -506 | $100.63 | $51k | 16,601 | Feb 26, 2025 |
| Feb 25, 2025 | John Patrick Darby EVP, Gen Counsel & Secretary | FTax withholding Encompass Health Common Stock | -509 | $100.63 | $51k | 80,126 | Feb 26, 2025 |
| Feb 25, 2025 | Andrew L Price Chief Accounting Officer | FTax withholding Encompass Health Common Stock | -410 | $100.63 | $41k | 69,891 | Feb 26, 2025 |
| Feb 25, 2025 | Mark J Tarr President & CEO | FTax withholding Encompass Health Common Stock | -2,896 | $100.63 | $291k | 529,257 | Feb 26, 2025 |
| Feb 25, 2025 | Edmund Fay Sr. Vice Pres. and Treasurer | FTax withholding Encompass Health Common Stock | -384 | $100.63 | $39k | 100,432 | Feb 26, 2025 |
| Feb 20, 2025 | Douglas E Coltharp EVP & Chief Financial Officer | AGrant or award Encompass Health Common Stock | +4,557 | $0.00 | $0 | 63,117 | Feb 21, 2025 |
| Feb 20, 2025 | Elissa Joy Charbonneau Chief Medical Officer | AGrant or award Encompass Health Common Stock | +1,939 | $0.00 | $0 | 17,542 | Feb 21, 2025 |
| Feb 20, 2025 | John Patrick Darby EVP, Gen Counsel & Secretary | AGrant or award Encompass Health Common Stock | +2,216 | $0.00 | $0 | 81,072 | Feb 21, 2025 |
| Feb 20, 2025 | Mark J Tarr President & CEO | AGrant or award Encompass Health Common Stock | +12,152 | $0.00 | $0 | 534,641 | Feb 21, 2025 |
| Feb 20, 2025 | Andrew L Price Chief Accounting Officer | AGrant or award Encompass Health Common Stock | +1,538 | $0.00 | $0 | 70,702 | Feb 21, 2025 |
| Feb 20, 2025 | Edmund Fay Sr. Vice Pres. and Treasurer | AGrant or award Encompass Health Common Stock | +1,404 | $0.00 | $0 | 101,190 | Feb 21, 2025 |
| Feb 13, 2025 | Andrew L Price Chief Accounting Officer | SOpen-market sale Encompass Health Common Stock | -5,042 | $98.29 | $496k | 69,164 | Feb 13, 2025 |
| Jan 15, 2025 | Greg D Carmichael director | AGrant or award Encompass Health Common Stock | +25 | $0.00 | $0 | 17,137 | Jan 17, 2025 |
| Jan 15, 2025 | Edward M Christie III director | AGrant or award Encompass Health Common Stock | +6 | $0.00 | $0 | 4,417 | Jan 17, 2025 |
| Jan 15, 2025 | Joan E Herman director | AGrant or award Encompass Health Common Stock | +83 | $0.00 | $0 | 46,105 | Jan 17, 2025 |
| Jan 15, 2025 | Leslye G Katz director | AGrant or award Encompass Health Common Stock | +83 | $0.00 | $0 | 46,105 | Jan 17, 2025 |
| Jan 15, 2025 | Patricia Anne Maryland director | AGrant or award Encompass Health Common Stock | +25 | $0.00 | $0 | 13,293 | Jan 17, 2025 |
| Jan 15, 2025 | Kevin J. O'Connor director | AGrant or award Encompass Health Common Stock | +14 | $0.00 | $0 | 8,429 | Jan 17, 2025 |
| Jan 15, 2025 | Christopher R Reidy director | AGrant or award Encompass Health Common Stock | +16 | $0.00 | $0 | 12,257 | Jan 17, 2025 |
| Jan 15, 2025 | Nancy M Schlichting director | AGrant or award Encompass Health Common Stock | +36 | $0.00 | $0 | 19,695 | Jan 17, 2025 |
| Jan 15, 2025 | Terrance Williams director | AGrant or award Encompass Health Common Stock | +25 | $0.00 | $0 | 13,647 | Jan 17, 2025 |
| Jan 16, 2025 | Edward M Christie III director | AGrant or award Encompass Health Common Stock | +292 | $94.40 | $28k | 4,709 | Jan 17, 2025 |
| Jan 16, 2025 | Christopher R Reidy director | AGrant or award Encompass Health Common Stock | +375 | $94.38 | $35k | 12,632 | Jan 17, 2025 |
| Jan 1, 2025 | Douglas E Coltharp EVP & Chief Financial Officer | FTax withholding Encompass Health Common Stock | -12,438 | $92.35 | $1.1M | 58,560 | Jan 3, 2025 |
| Jan 1, 2025 | Elissa Joy Charbonneau Chief Medical Officer | FTax withholding Encompass Health Common Stock | -2,991 | $92.35 | $276k | 15,603 | Jan 3, 2025 |
| Jan 1, 2025 | John Patrick Darby EVP, Gen Counsel & Secretary | FTax withholding Encompass Health Common Stock | -5,917 | $92.35 | $546k | 78,856 | Jan 3, 2025 |
| Jan 1, 2025 | Andrew L Price Chief Accounting Officer | FTax withholding Encompass Health Common Stock | -2,446 | $92.35 | $226k | 74,206 | Jan 3, 2025 |
| Jan 1, 2025 | Edmund Fay Sr. Vice Pres. and Treasurer | FTax withholding Encompass Health Common Stock | -2,291 | $92.35 | $212k | 99,786 | Jan 3, 2025 |
| Jan 1, 2025 | Mark J Tarr President & CEO | FTax withholding Encompass Health Common Stock | -31,609 | $92.35 | $2.9M | 522,489 | Jan 3, 2025 |
| Nov 13, 2024 | Douglas E Coltharp EVP & Chief Financial Officer | GGift Encompass Health Common Stock | -65,229 | $0.00 | $0 | 70,998 | Nov 13, 2024 |
| Nov 13, 2024 | Douglas E Coltharp EVP & Chief Financial Officer | GGift Encompass Health Common Stockindirect: By spouse | +65,229 | $0.00 | $0 | 65,229 | Nov 13, 2024 |
| Oct 15, 2024 | Kevin J. O'Connor director | AGrant or award Encompass Health Common Stock | +14 | $0.00 | $0 | 8,415 | Oct 17, 2024 |
| Oct 15, 2024 | Patricia Anne Maryland director | AGrant or award Encompass Health Common Stock | +24 | $0.00 | $0 | 13,268 | Oct 17, 2024 |
| Oct 15, 2024 | Leslye G Katz director | AGrant or award Encompass Health Common Stock | +81 | $0.00 | $0 | 46,022 | Oct 17, 2024 |
| Oct 15, 2024 | Edward M Christie III director | AGrant or award Encompass Health Common Stock | +6 | $0.00 | $0 | 4,128 | Oct 17, 2024 |
| Oct 15, 2024 | Joan E Herman director | AGrant or award Encompass Health Common Stock | +81 | $0.00 | $0 | 46,022 | Oct 17, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Greg D Carmichaeldirector
- Douglas E ColtharpEVP & Chief Financial Officer
- Elissa Joy CharbonneauChief Medical Officer
- Edward M Christie IIIdirector, ceo, president, officer
- John Patrick DarbyEVP, Gen Counsel & Secretary
- Edmund FaySr. Vice Pres. and Treasurer
- Joan E Hermandirector
- Leslye G Katzdirector
- Patricia Anne Marylanddirector
- Kevin J. O'Connorofficer, director
- Andrew L PriceChief Accounting Officer
- Christopher R Reidydirector
- Nancy M Schlichtingdirector
- Mark J TarrPresident & CEO
- Patrick William TuerEVP, Chief Operating Officer
- Terrance Williamsdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.